Star Imaging and Path Lab IPO Details
Star Imaging and Path Lab IPO Summary
Star Imaging and Path Lab IPO opens for subscription on 08 Aug 2025 and closes on 12 Aug 2025.The IPO will be listed on BSE with the tentative listing date set for 18 Aug 2025.
Star Imaging and Path Lab IPO price band has been fixed at ₹135 – ₹142 per share. The face value is ₹10 per share with a lot size of 1000.
Star Imaging and Path Lab IPO total issue size comprises 48,92,000 shares (aggregating up to ₹69.47 Cr). This includes a fresh issue of 39,20,000 shares (aggregating up to ₹55.66 Cr). Offer for Sale consists of 9,72,000 shares (aggregating up to ₹13.80 Cr). Pre-issue shareholding stands at 1,35,00,000, which will increase to 1,74,20,000 post-issue.
Star Imaging and Path Lab IPO carries a ₹5 (3.52%) GMP, reflecting investor sentiment.
Star Imaging and Path Lab IPO Lot Size :Individual Minimum is 2 lots (2,000 shares) amounting to ₹284,000. Individual Maximum is 2 lots (2,000 shares) amounting to ₹284,000. SHNI Minimum is 3 lots (3,000 shares) amounting to ₹426,000. SHNI Maximum is 7 lots (7,000 shares) amounting to ₹994,000. BHNI Minimum is 8 lots (8,000 shares) amounting to ₹1,136,000.
The Lead Managers for Star Imaging and Path Lab IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Share India Capital Services Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Share India Securities Ltd. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Star Imaging and Path Lab Limited RHP.
Star Imaging and Path Lab IPO Details
Star Imaging and Path Lab IPO Subscription
Star Imaging and Path Lab IPO Application Wise Breakup
Star Imaging and Path Lab IPO Dates
- 08 Aug 2025Opening dateOpen
- 12 Aug 2025Closing dateClose
- 13 Aug 2025Allotment Date Allotment
- 14 Aug 2025Initiation of RefundsRefund
- 14 Aug 2025Credit of SharesCredit
- 18 Aug 2025Listing dateListing
Star Imaging and Path Lab IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2000 | ₹284,000 |
| Individual Maximum | 2 | 2000 | ₹284,000 |
| SHNI Minimum | 3 | 3000 | ₹426,000 |
| SHNI Maximum | 7 | 7000 | ₹994,000 |
| BHNI Minimum | 8 | 8000 | ₹1,136,000 |
Star Imaging and Path Lab IPO Reservation
Promoter Holding
Documents
Star Imaging and Path Lab IPO Valuations
Star Imaging and Path Lab Financial Information
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 82.64 | 81.64 | 61.23 | 58.34 |
| Total Income | 42.67 | 79.97 | 58.68 | 69.27 |
| Profit After Tax | 6.21 | 12.45 | 0.58 | 6.29 |
| Net Worth | 37.56 | 31.35 | 18.93 | 18.36 |
| Reserves and Surplus | 36.06 | 29.85 | 17.43 | 16.86 |
| Total Borrowing | 29.29 | 30.64 | 26.56 | 29.56 |
| Amount in ₹ Crore | ||||
About Star Imaging and Path Lab IPO
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.
The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics.
With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment.
The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions.
Strength Of Star Imaging and Path Lab IPO
1. Integrated diagnostics provider with one-stop solution offering pathology and radiology services.
2. Established presence and proven track record.
3. Dedicated management team with significant industry experience.
Risk Of Star Imaging and Path Lab IPO
1. Our Company, Promoter and Directors are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition.
2. There have been instances in the past where we have not made regulatory filing of Consolidated Financials of our Company with RoC.
3. Our Company has reported certain negative cash flows from its operating activity, investing activity and financing activity, details of which are given below.
4. Our Company has not fulfilled its CSR obligation u/s 135 of the Companies Act, 2013 for the F.Y. 2021-22 to F.Y. 2023-24. Such noncompliance/ default may attract penalties on the Company and its Directors.
5. Form-2 for Return of Allotment filed with the Registrar of Companies for the period April 28, 2011 is not traceable.
6. There were certain instances of discrepancies in relation to certain statutory filings and corporate records of our Company.
7. We do not own registered office which is used by us currently.
8. Our inability to protect or use our intellectual property rights or comply with intellectual property rights of others may adversely affect our business and results of operations.
9. We have in the past entered into related party transactions and may continue to do so in the future, which may potentially involve conflicts of interest with the equity shareholders.
10. Our future funds requirements, in the form of issue of capital or securities and/or loans taken by us, may be prejudicial to the interest of the shareholders depending upon the terms on which they are eventually raised.
Objectives Star Imaging and Path Lab IPO
1. To Meet Working Capital Requirement
2. Repayment/prepayment of certain borrowings availed of by the Company
3. Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities
4. General corporate purposes
Company Contact Details
Star Imaging & Path Lab Ltd.
4B/4,
Tilak Nagar, Near Sant Pura,
Tilak Nagar West Delhi, New Delhi- 110018
New Delhi, New Delhi, 110018
Phone: +91 9990019189
Email: cs@starimaging.in
Website: https://www.starimaging.in/
Registrar Contact Details
Star Imaging and Path Lab FAQs
The Star Imaging and Path Lab IPO is a SME public issue comprising 4892000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹69.47 Cr. The issue price has been fixed at ₹142 per equity share, and the minimum application size is 1000 shares.
The IPO opens for subscription on 08 Aug 2025, and closes on 12 Aug 2025.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE
As of now, the current GMP stands at ₹5 (3.52%).
Quick Links
Comments
